Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Equity: 2021-2025

Historic Return on Equity for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to -0.48%.

  • Maravai Lifesciences Holdings' Return on Equity fell 1.00% to -0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.48%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.38% for FY2024, which is 22.00% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Return on Equity stood at -0.48%, which was up 30.48% from -0.68% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Return on Equity registered a high of 0.97% during Q2 2021, and its lowest value of -0.68% during Q2 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Return on Equity averaged around -0.23%, with its median value being -0.21% (2024).
  • In the last 5 years, Maravai Lifesciences Holdings' Return on Equity climbed by 19bps in 2022 and then plummeted by 73bps in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Return on Equity (Quarterly) stood at 0.94% in 2021, then crashed by 38bps to 0.56% in 2022, then crashed by 73bps to -0.16% in 2023, then declined by 27bps to -0.44% in 2024, then decreased by 1bps to -0.48% in 2025.
  • Its Return on Equity was -0.48% in Q3 2025, compared to -0.68% in Q2 2025 and -0.52% in Q1 2025.